Form 8-K - Current report:
SEC Accession No. 0001193125-25-054905
Filing Date
2025-03-14
Accepted
2025-03-14 17:25:52
Documents
16
Period of Report
2025-03-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d934152d8k.htm   iXBRL 8-K 74149
2 EX-2.1 d934152dex21.htm EX-2.1 732919
3 EX-10.1 d934152dex101.htm EX-10.1 53491
4 EX-10.2 d934152dex102.htm EX-10.2 11187
  Complete submission text file 0001193125-25-054905.txt   1186869

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ndoi-20250313.xsd EX-101.SCH 2841
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ndoi-20250313_lab.xml EX-101.LAB 15198
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ndoi-20250313_pre.xml EX-101.PRE 9537
18 EXTRACTED XBRL INSTANCE DOCUMENT d934152d8k_htm.xml XML 3106
Mailing Address 9 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 9 GREAT VALLEY PARKWAY MALVERN PA 19355 (484) 216-0000
Endo, Inc. (Filer) CIK: 0002008861 (see all company filings)

EIN.: 301390281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-280767 | Film No.: 25741406
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)